Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
NCT00255060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2010-07-20
Summary
To screen women who are high risk for breast cancer with breast MRI, mammogram and random periareolar fine needle aspiration.
Conditions
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
United States Department of Defense
collaborator FED - lead OTHER
Principal Investigators
-
James M Ford · Stanford University
Eligibility
- Min Age
- 25 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-11-30
- Primary Completion
- 2006-07-31
- Completion
- 2007-06-30
Countries
- United States
Study Locations
More Related Trials
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
Women At Risk: The High Risk Breast Cancer Program
NCT01034891 ·Status: UNKNOWN
-
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891 ·Status: COMPLETED ·Phase: NA
-
High Risk Breast Cancer Screening Program
NCT00509509 ·Status: UNKNOWN
-
Biomarkers for Breast Cancer Risk in African American Women
NCT01736306 ·Status: COMPLETED
-
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703 ·Status: RECRUITING
-
Cell Lines From High-Risk Breast Tissue
NCT00032201 ·Status: COMPLETED
-
Magnetic Resonance Imaging of Breast Cancer
NCT01035112 ·Status: RECRUITING ·Phase: NA
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot
NCT04002986 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
NCT07076147 ·Status: RECRUITING
-
Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening
NCT03372902 ·Status: COMPLETED
-
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol
NCT02078570 ·Status: UNKNOWN
-
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
NCT00695968 ·Status: TERMINATED
-
Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer
NCT00072501 ·Status: COMPLETED ·Phase: NA
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer
NCT06950008 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
High Risk Screening Breast MR Using a Rapid Imaging Exam
NCT00588614 ·Status: COMPLETED
-
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
NCT00898508 ·Status: COMPLETED
-
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
NCT00003736 ·Status: COMPLETED ·Phase: NA
-
Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate Risk
NCT02210546 ·Status: UNKNOWN ·Phase: NA
-
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer
NCT05130840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Candidate Protein Expression in Breast Cancer Specimens
NCT00918892 ·Status: COMPLETED